* SSRIs:Selective Serotonin Reuptake Inhibitors(选择性血清素再摄取抑制剂)。在医学语境中,通常保留为 SSRIs 或翻译为“选择性血清素再摄取抑制剂”。由于提示要求专业科技翻译,我应该使用标准的中文术语。
* boosted:增强,提高。
* ability of T cells to kill cancer cells:T细胞杀伤癌细胞的能力。
* suppressed:抑制。
The team also investigated whether combining SSRIs with existing cancer therapies could improve treatment outcomes. * *Draft:* 研究团队还调查了将SSRIs与现有癌症疗法联合使用是否能改善治疗结果。 * *Refinement:* "Treatment outcomes" -> 治疗效果/预后. "Improve" -> 改善/提高. * *Sentence 3:* They tested a combination of an SSRI and anti-PD-1 antibody -- a common immune checkpoint blockade, or ICB, therapy -- in mouse models of melanoma and colon cancer. * *Key terms:* anti-PD-1 antibody (抗PD-1抗体), immune checkpoint blockade (免疫检查点阻断), ICB, melanoma (黑色素瘤), colon cancer (结肠癌). * *Draft:* 他们在黑色素瘤和结肠癌小鼠模型中测试了SSRI与抗PD-1抗体(一种常见的免疫检查点阻断疗法,即ICB疗法)的联合使用。 * *Sentence 4:* ICB therapies work by blocking immune checkpoint molecules that normally suppress immune cell activity, allowing T cells to attack tumors more effectively. * *Draft:* ICB疗法通过阻断通常抑制免疫细胞活性的免疫检查点分子发挥作用,使T细胞能更有效地攻击肿瘤。 * *Sentence 5:*
The results were striking: the combination significantly reduced tumor size in all treated mice and even achieved complete remission in some cases. * *Key terms:* striking (显著的/令人瞩目的), complete remission (完全缓解). * *Draft:* 结果令人瞩目:该联合疗法显著缩小了所有受治小鼠的肿瘤体积,甚至在某些情况下实现了完全缓解。 * *Sentence 6:* "Immune checkpoint blockades are effective in fewer than 25% of patients," said James Elsten-Brown, a graduate student in the Yang lab and co-author of the study. * *Draft:* “免疫检查点阻断疗法仅在不到25%的患者中有效,”杨实验室的研究生、该研究的合著者James Elsten-Brown说道。 * *Sentence 7:* "If a safe, widely available drug like an SSRI could make these therapies more effective, it would be hugely impactful." * *Draft:* “如果像SSRI这样安全且广泛可得的药物能让这些疗法更有效,那将产生巨大的影响。” * *Sentence 8:*
To confirm these findings, the team will investigate whether real-world cancer patients taking SSRIs have better outcomes, especially those receiving ICB therapies. * *Draft:* 为了证实这些发现,团队将调查现实世界中服用SSRIs的癌症患者是否有更好的预后,特别是那些正在接受ICB疗法的患者。 * *Refinement:* "Outcomes" here usually refers to clinical outcomes/prognosis -> 预后/治疗结果. * *Sentence 9:* "Since around 20% of cancer patients take antidepressants -- most commonly SSRIs -- we see a unique opportunity to explore how these drugs might improve cancer outcomes," said Yang, who is also a member of the Goodman-Luskin Microbiome Center and the Parker Institute for Cancer Immunotherapy. * *Key terms:* Goodman-Luskin Microbiome Center (古德曼-拉斯金微生物组中心), Parker Institute for Cancer Immunotherapy (帕克癌症免疫治疗研究所). * *Draft:* “由于约20%的癌症患者服用抗抑郁药物——最常见的是SSRIs——我们看到了一个独特的机会来探索这些药物如何改善癌症预后,”杨说道,她也是古德曼-拉斯金微生物组中心和帕克癌症免疫治疗研究所的成员。 * *Sentence 10:* "Our goal is to design a clinical trial to compare treatment outcomes between cancer patients who take these medications and those who do not." * *Draft:* “我们的目标是设计一项临床试验,比较服用这些药物的癌症患者与未服用患者的治疗结果。” * *Sentence 11:*
Yang added that using existing FDA-approved drugs could speed up the process of bringing new cancer treatments to patients, making this research especially promising. * *Draft:* 杨补充道,使用现有的FDA批准药物可以加快向患者提供新癌症疗法的进程,这使得该研究前景尤为广阔。 * *Sentence 12:* "Studies estimate the bench-to-bedside pipeline for new cancer therapies costs an average of $1.5 billion," she said. * *Key terms:* bench-to-bedside pipeline (从实验室到临床的转化过程/管线). * *Draft:* “研究估计,新癌症疗法从实验室到临床的转化过程平均耗资15亿美元,”她说。 * *Sentence 13:* "When you compare this to the estimated $300 million cost to repurpose FDA-approved drugs, it's clear why this approach has so much potential." * *Key terms:* repurpose (老药新用/重新定位). * *Draft:* “当你将其与老药新用FDA批准药物估计所需的3亿美元成本相比,就很清楚为什么这种方法具有如此大的潜力了。” * *Sentence 14:*
The newly identified therapeutic strategy is covered by a patent application filed by the UCLA Technology Development Group on behalf of the Regents of the University of California, with Yang and Li as co-inventors. * *Key terms:* therapeutic strategy (治疗策略), patent application (专利申请), UCLA Technology Development Group (加州大学洛杉矶分校技术发展集团), Regents of the University of California (加州大学校董会), co-inventors (共同发明人). * *Draft:* 这一新发现的治疗策略已由加州大学洛杉矶分校技术发展集团代表加州大学校董会提交了专利申请,杨和Li为共同发明人。 * *Sentence 15:*
This research was supported by the National Institutes of Health, the California Institute for Regenerative Medicine, the Tower Cancer Research Foundation, a UCLA Broad Stem Cell Research Center Rose Hills Foundation Innovator Grant and a UCLA Jonsson Comprehensive Cancer Center and Broad Stem Cell Research Center Ablon Scholars Award. * *Key terms:* National Institutes of Health (美国国立卫生研究院), California Institute for Regenerative Medicine (加州再生医学研究所), Tower Cancer Research Foundation (塔楼癌症研究基金会), UCLA Broad Stem Cell Research Center (加州大学洛杉矶分校布罗德干细胞研究中心), Rose Hills Foundation Innovator Grant (罗斯希尔基金会创新者资助), Ablon Scholars Award (阿布隆学者奖). * *Draft:* 该研究得到了美国国立卫生研究院、加州再生医学研究所、塔楼癌症研究基金会、加州大学洛杉矶分校布罗德干细胞研究中心罗斯希尔基金会创新者资助,以及加州大学洛杉矶 * *Let's check the introductory phrase:* "Additional UCLA authors include:" -> "加州大学洛杉矶分校(UCLA)的其他作者包括:" or simply "UCLA的其他作者包括:". Usually, full university names are preferred in formal contexts. * *Draft Translation:* 加州大学洛杉矶分校的其他作者包括:Miao Li, Enbo Zhu, Zhe Li, Yuning Chen, Elliot Kang, Feiyang Ma, Jennifer Chiang, Yan-Ruide Li, Yichen Zhu, Jie Huang, Audrey Fung, Quentin Scarborough, Robin Cadd, Jin J. Zhou, Arnold I. Chin 和 Matteo Pellegrini。 * *Refining the "UCLA" part:* Should I keep "UCLA" or write "加州大学洛杉矶分校"? Usually, "UCLA" is widely recognized, but "加州大学洛杉矶分校" is the formal translation. I will use the formal translation. * *Refining the names:* If I try to translate them, I risk errors. For example, "Chin" can be 钱, 秦, 陈. "Zhu" can be 朱, 祝. "Li" can be 李, 黎. Without the specific paper's Chinese abstract or author profile, guessing is unprofessional. Therefore, keeping names in English is the correct choice for a "professional tech translator" persona focused on accuracy. * *Handling the HTML tag:* The source text ends with `
`. The user asked to translate the content. I should probably strip the HTML tag for the output unless the user wants the format preserved. The prompt says "translate the following content", usually implying the text. However, often in these tasks, preserving the format is good. But the prompt says "Only output the translation result". A clean text output is usually best. I will output the text without the HTML tag, as it's likely a copy-paste artifact. Wait, looking at the source ``, it suggests it was copied from a webpage. I will provide the clean Chinese text. * *Final Polish:* "Additional UCLA authors include:" -> 加州大学洛杉矶分校的其他作者包括: List of names -> Keep as is. "and" -> 和 / 以及. * *Result:* 加州大学洛杉矶分校的其他作者包括:Miao Li, Enbo Zhu, Zhe Li, Yuning Chen, Elliot Kang, Feiyang Ma, Jennifer Chiang, Yan-Ruide Li, Yichen Zhu, Jie Huang, Audrey Fung, Quentin Scarborough, Robin Cadd, Jin J. Zhou, Arnold I. Chin 和 Matteo Pellegrini。 * *Self-Correction:* Is there any chance the user wants the names transliterated? In Chinese scientific journals, when citing foreign papers, names are often left in English, or transliterated if very famous. For a list of co-authors, English is standard to ensure correct attribution. * *One detail:* "UCLA authors". Does it mean authors *from* UCLA? Yes. * *Translation:* 加州大学洛杉矶分校的其他作者包括:Miao Li、Enbo Zhu、Zhe Li、Yuning Chen、Elliot Kang、Feiyang Ma、Jennifer Chiang、Yan-Ruide Li、Yichen Zhu、Jie Huang、Audrey Fung、Quentin Scarborough、Robin Cadd、Jin J. Zhou、Arnold I. Chin 和 Matteo Pellegrini。 * *Punctuation:* Chinese enumeration usually uses enumeration commas (、) between names, and "和" before the last one. However, since the names are in English (First Last format), using commas (,) as in the original English list is also acceptable and often preferred to avoid confusion with the name structure, but using enumeration commas (、) is more "Chinese". Let's stick to the standard Chinese punctuation for lists if possible, or keep the English commas if it looks cleaner. * Actually, for English names in a Chinese sentence, using commas is often clearer because English names contain spaces. Using "、" might look like: Miao Li、Enbo Zhu. This is fine. * Let's check standard practice. Usually: "作者包括 A, B, C 和 D." or "作者包括 A、B、C 和 D。" * I will use commas to separate the English names as it preserves the integrity of the "First Name Last Name" blocks better visually, or use the enumeration comma. Let's use the enumeration comma (、) as it is grammatically correct for Chinese text, but standard commas are also very common for English name lists. I will use standard commas to match the source structure closely, or enumeration commas. Let's go with enumeration commas for a polished Chinese feel, or just commas. * Let's look at the source again. It uses commas. * Let's try to find if this is a real paper to see if there are official Chinese names. * Search query mental check: "UCLA authors Miao Li Enbo Zhu". This looks like a paper on single-cell sequencing or similar biology field. * Found a match: "Single-cell analysis of human monocytes..." or similar. * Authors: Miao Li (李淼?), Enbo Zhu (朱恩波?), etc. * Since I cannot be 100% sure of the characters without the specific paper's Chinese press release, I must stick to the English names. * *Final Decision on Punctuation:* I will use commas to separate the names because English names have spaces, and mixing them with enumeration commas can sometimes look cluttered, though both are acceptable. I will use "和" for "